Articles tagged "Kidney"

2020 American Transplant Congress
Quantifying the Number of ESRD Patients Who Might Benefit from Bariatric Surgery to Achieve Listing for Transplant
B. Orandi¹, P. MacLennan¹, S. Mehta¹, J. Grams¹, R. Stahl¹, R. Cannon¹, D. Anderson¹, M. Hanaway¹, C. Young¹, J. Purvis¹, N. Terrault², C. Lewis¹, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Southern California, Los Angeles, CA
*Purpose: Mounting evidence suggests bariatric surgery may play a role in helping obese ESRD patients achieve sufficient weight loss to be transplant-eligible. We sought to…
2020 American Transplant Congress
Hematopoietic Cell Kinase Promotes Kidney Fibrosis Through Autophagy Pathway
C. Wei, L. Mou, K. Banu, M. Menon, W. Zhang, C. He, B. Murphy
Icahn School of Medicine at Mount Sinai, New York, NY
*Purpose: In our previous studies, we identified hematopoietic cell kinase (HCK) as a key driver of renal fibrosis through TGFβ/Smad3 pathway. Here in this study,…
2020 American Transplant Congress
Post- Transplant Recurrence of IgA Nephropathy: HLA as a Predictive Factor
C. R. Kavanagh¹, N. G. Jain¹, R. Vasilescu², J. Kamal³, I. Batal²
¹Pediatric Nephrology, Columbia University Medical Center, New York, NY, ²Pathology, Columbia University Medical Center, New York, NY, ³Surgery, Columbia University Medical Center, New York, NY
*Purpose: Genomic studies have identified several HLA antigens to be associated with IgA Nephropathy in the native kidney. In contrast to the native kidney, there…
2020 American Transplant Congress
Safety of Belatacept in HIV-Positive Kidney Transplant Recipients
K. El Sakhawi¹, A. Scemla², D. Bertrand³, C. Garrouste⁴, P. Malvezzi⁵, P. Grimbert¹, M. Matignon¹
¹Nephrology, APHP Henri Mondor, Créteil, France, ²Nephrology, APHP Necker Enfants Malades, Paris, France, ³Nephrology, CHU Bois Guillaume, Rouen, France, ⁴Nephrology, CHU Clermond Ferrand, Clermont Ferrand, France, ⁵Nephrology, CHU Grenoble, Grenoble, France
*Purpose: Kidney allograft survival in HIV-infected patients is lower than in the general population. Belatacept (instead of anticalcineurins (CNI)) has been shown to have a…
2020 American Transplant Congress
Identifying Factors Associated with Delayed Graft Function Severity Using the OPTN Database
K. Checchi¹, D. Stewart², A. Toll², J. Case¹, S. Kurian¹, C. Marsh¹
¹Scripps Health, La Jolla, CA, ²United Network for Organ Sharing Research Department, Richmond, VA
*Purpose: Delayed graft function (DGF) is a costly adverse outcome in kidney transplantation with negative implications for both graft and patient survival. Identifying factors associated…
2020 American Transplant Congress
Choice of Mitral Valve and Aortic Valve for Replacement for ESRD Patients Eligible for Kidney Transplant: A USRDS Analysis
N. Sarabu¹, D. Ngendahimana², L. Al Dahabre³, K. Lentine⁴, K. Chavin¹, T. Srinivas¹, S. Deo²
¹University Hospitals Cleveland, Cleveland, OH, ²Case Western Reserve University, Cleveland, OH, ³University Hospitals of Cleveland, Cleveland, OH, ⁴Saint Louis University, Saint Louis, MO
*Purpose: Tissue valve (TiV) may be preferred over mechanical valve (meV) in ESRD patients for valve replacement. Among ESRD patients who are kidney transplant eligible,…
2020 American Transplant Congress
The Trend of Non-Utilization and Decline of Hepatitis C Virus Antibody-Positive Deceased Donor Kidneys
S. Chang¹, K. Lentine², D. Axelrod³, J. Wellen¹, M. Wang¹, M. A. Schnitzler⁴, T. Alhamad⁵
¹Surgery, Washington University School of Medicine, Saint Louis, MO, ²Surgery, Saint Louis University, Saint Louis, MO, ³Surgery, University of Iowa, Iowa City, IA, ⁴Surgery, Sanit Louis University, Saint Louis, MO, ⁵Washington University School of Medicine, Saint Louis, MO
*Purpose: With more transplant centers are accepting hepatitis C virus infected (HCV+) deceased donor kidneys (dHCV+), the trend of non-utilization and decline of these organs…
2020 American Transplant Congress
Delayed Graft Function in the Recipients of Simultaneous Liver and Kidney Transplant: A Single-Center Experience
F. Aziz, B. Muth, N. Garg, M. Mohamed, D. Mandelbrot, J. Mezrich, A. Djamali, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Increased rates of delayed graft function (DGF) have been reported in the recipients of simultaneous liver and kidney (SLK) transplant. However, the effect of…
2020 American Transplant Congress
Donor-Derived Cell-Free DNA for Detection of Cell-Mediated Rejection in Low Risk Kidney Transplant Patients
S. Anand, L. Dong, M. Fife, J. Krong, S. Dow, D. Morris, T. Srinivas
Intermountain Medical Center, Murray, UT
*Purpose: Donor-derived cell free DNA (dd-cfDNA) is an emerging non-invasive biomarker for kidney allograft rejection. This has not been externally validated in low risk population.…
2020 American Transplant Congress
Impact of a Pharmacist Led Outpatient Tacrolimus Monitoring Protocol in Renal Transplant Recipients
K. L. Owen, M. Palettas, H. Winters, T. E. Pesavento, A. Rajab, O. Witkowsky
Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: The purpose of this study is to compare the time within therapeutic range (TTR) of tacrolimus (TAC) before and after the initiation of a…